IND Enabling Study to prepare Silo Pharma Homing Peptides for Clinic ENGLEWOOD CLIFFS, N.J., March 31, 2022 (GLOBE NEWSWIRE) — Silo Pharma, Inc. (OTCQB: SILO), a development-stage biopharmaceutical company focused on the use of psychedelics as a therapeutic, today announces that it has entered into an agreement with Frontage Laboratories, a CRO (contract research organization)…
